Harnessing QSAR and machine learning for the design of hepatocellular carcinoma inhibitors; experimental validation of the cytotoxicity of new compounds against HepG2 cells

Medicine in Drug Discovery · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles